. 2015 Sep 3;2015(9):CD000020. doi: 10.1002/14651858.CD000020.pub3

000157.

Trial name or title	A clinical trial to study the effect of injection of anti‐D administered during pregnancy for Rh‐negative mothers.
Methods	Randomised controlled trial.
Participants	Recruitment target: 100 women. Setting: Dr TMA Pai Rotary Hospital, Karkala, India. Inclusion criteria: all Rh‐negative and indirect agglutinin test negative primigravida and un‐sensitised multigravida who are willing to participate in the study. Exclusion criteria: all Rh‐negative mothers with Rh‐negative husbands. Indirect agglutination test positive.
Interventions	Treatment group: antenatal administration of 300 µg (1500 IU) of Rh‐D immunoglobulin. Control group: no intervention.
Outcomes	Primary outcomes: incidence of immunisation during pregnancy at term, at delivery and at 6 months. Secondary outcomes: incidence of neonatal hyperbilirubinaemia, need for exchange transfusion, and need for phototherapy.
Starting date	1/12/2008 on the trial registry however, the trial is listed as "not yet recruiting".
Contact information	Scientific queries: Dr AP Manjunath Associate Professor Department of Obstetrics and Gynaecology 576104, India Phone: 09845913140 Fax: 080257061 Email: manjunanth.ap@manipal.edu
Notes

IU: international units